高玉霞, 李红雨, 班振英, 张红岩, 贾冬丽, 姚俊阁, 马学玲. 卵巢上皮性癌组织中DAPK基因启动子甲基化及其蛋白表达的研究[J]. 中国肿瘤临床, 2013, 40(6): 319-322, 327. DOI: 10.3969/j.issn.1000-8179.2013.06.005
引用本文: 高玉霞, 李红雨, 班振英, 张红岩, 贾冬丽, 姚俊阁, 马学玲. 卵巢上皮性癌组织中DAPK基因启动子甲基化及其蛋白表达的研究[J]. 中国肿瘤临床, 2013, 40(6): 319-322, 327. DOI: 10.3969/j.issn.1000-8179.2013.06.005
shu
Yu-xia GAO, Hong-yu LI, Zhen-ying BAN, Hong-yan ZHANG, Dong-li JIA, Jun-ge YAO, Xue-ling MA. Methylation and protein expression of death-associated protein kinase promoter in epithelial ovarian carcinomas[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(6): 319-322, 327. DOI: 10.3969/j.issn.1000-8179.2013.06.005
Citation: Yu-xia GAO, Hong-yu LI, Zhen-ying BAN, Hong-yan ZHANG, Dong-li JIA, Jun-ge YAO, Xue-ling MA. Methylation and protein expression of death-associated protein kinase promoter in epithelial ovarian carcinomas[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(6): 319-322, 327. DOI: 10.3969/j.issn.1000-8179.2013.06.005
shu

卵巢上皮性癌组织中DAPK基因启动子甲基化及其蛋白表达的研究

Methylation and protein expression of death-associated protein kinase promoter in epithelial ovarian carcinomas

    摘要
  • 摘要:
      目的  研究卵巢上皮性癌组织中DAPK基因启动子甲基化及其蛋白表达在卵巢癌发生发展过程中的作用及意义。
      方法  应用甲基化特异性PCR(MSP)检测55例卵巢上皮性癌(恶性组)、25例卵巢交界性上皮性肿瘤(交界组)、30例卵巢良性上皮性肿瘤(良性组)、25例正常卵巢上皮组织(正常组)的石蜡包埋组织中DAPK基因启动子的甲基化情况。应用免疫组织化学链霉菌抗生物素蛋白-过氧化物酶连接(S-P)法检测上述蜡块组织中DAPK蛋白的表达情况。
      结果  DAPK启动子在正常组、良性组、交界组、恶性组的甲基化率分别为0(0/25)、6.7%(2/30)、16.0%(4/25)、47.3%(26/55), 差异有统计学意义(P < 0.001), 恶性组的甲基化率高于其他三组; DAPK蛋白在正常组、良性组、交界组、恶性组的阳性表达率分别为96.0%(24/25)、90.0%(27/30)、48.0%(12/25)、30.9%(17/55), 差异有统计学意义(P < 0.001), 恶性组、交界组的阳性表达率均低于正常组和良性组; DAPK基因启动子甲基化和DAPK蛋白表达呈负相关。
      结论  DAPK基因启动子甲基化导致基因沉默、失活, 引起蛋白表达下调或缺失, 并参与了卵巢上皮性癌的发生发展。

     

    Abstract:
      Objective  This study aimed to investigate the methylation and protein expression of death-associated protein kinase(DAPK) promoter in epithelial ovarian carcinoma(EOC).This study also aimed to evaluate the functions of DAPK methylation and protein expression in EOC development.
      Methods  Methylation-specific polymerase chain reaction was performed to detect DAPK promoter methylation in paraffin-embedded tissue specimens.The following specimens were examined: 55 cases of EOC tissues(malignant group); 25 borderline epithelial ovarian neoplasms(borderline group); 30 cases of benign epithelial ovarian neoplasms(benign group); and 25 cases of normal epithelial ovarian tissue(normal group).Immunohistochemical streptavidin-peroxidase method was also performed to assess DAPK expression in the aforementioned specimens.
      Results  The rate of DAPK promoter methylation was 0%(0/25), 6.7%(2/30), 16.0%(4/25), and 47.3%(26/55) in normal, benign, borderline, and malignant groups, respectively.This rate was significantly higher in the malignant group than in the three groups(P < 0.008 3).The rate of DAPK-positive protein expression was 96.0%(24/25), 90.0%(27/30), 48.0%(12/25), and 30.9%(17/55) in normal, benign, borderline, and malignant groups, respectively.This rate was significantly lower both in malignant and borderline groups than that in benign and normal groups, respectively(P < 0.008 3).Thus, DAPK promoter methylation was negatively correlated with its protein expression.
      Conclusion  DAPK promoter methylation caused gene silencing and inactivity, thereby resulting in downregulation or loss of DAPK promoter protein expression, which contributed to oncogenesis and progression of EOCs.

     

    • HTML全文
    • 参考文献(15)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回